| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $25,124,011 ) (Continued on the next page) |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS127292 | Molecular mechanisms for sorting lysosomal proteins | 000 | 5 | NIH | 6/3/2026 | $475,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AI194519 | Investigating KDM5C as a regulatory switch between anabolic and catabolic metabolism | 000 | 1 | NIH | 4/24/2026 | $886,437 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | DP2CA325383 | Single-molecule, Single-cell profiling of chromatin protein-protein interactions. | 000 | 1 | NIH | 9/10/2026 | $912,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30NS149794 | Dissecting neuronal molecular trajectories and glial responses to α-synuclein aggregates in Lewy body diseases | 002 | 1 | NIH | 7/6/2026 | $0 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30NS149794 | Dissecting neuronal molecular trajectories and glial responses to α-synuclein aggregates in Lewy body diseases | 001 | 1 | NIH | 7/6/2026 | $0 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30NS149794 | Dissecting neuronal molecular trajectories and glial responses to α-synuclein aggregates in Lewy body diseases | 000 | 1 | NIH | 7/6/2026 | $52,114 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R00CA286742 | The role of AHR in modulatingimmunotherapy response and adverse events in bladder cancer | 000 | 4 | NIH | 6/26/2026 | $183,769 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS142598 | Mechanisms of gain-of-repeat-toxicity and loss-of-C9ORF72-function in FTD and ALS | 000 | 1 | NIH | 2/27/2026 | $555,128 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM165630 | Regulation of Endoplasmic Reticulum (ER) Quality Control Across Cell types with Unique ER morphologies. | 000 | 1 | NIH | 7/1/2026 | $528,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R50CA315355 | Regulation of DNA methylation inheritance in colon cancer | 000 | 1 | NIH | 8/6/2026 | $119,105 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R50CA305793 | Development and Improvement of Research Software for DNA Methylation and RNA Sequencing Analysis | 000 | 1 | NIH | 8/31/2026 | $190,764 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R21HD119634 | Developmental reprogramming by gene environment interactions | 000 | 1 | NIH | 7/30/2026 | $528,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA269394 | Harnessing the therapeutic potential of histotripsy focused ultrasound-induced immunogenic cancer cell death | 000 | 5 | NIH | 5/14/2026 | $496,922 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | K99CA293261 | Targeting PTGIR-Prostacyclin Signaling to Overcome T Cell Exhaustion and Enhance Anti-Tumor Immunity | 000 | 2 | NIH | 7/14/2026 | $112,234 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM160317 | Revealing the Molecular Basis of Microtubule-Intermediate Filament Interactions. | 000 | 2 | NIH | 6/3/2026 | $528,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AI188367 | Metabolic targeting of CD4 T cells in CNS autoimmunity | 001 | 2 | NIH | 7/28/2026 | $790,222 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R21HD114905 | Fatty acid metabolism in disease models of mitochondrial fatty acid synthesis deficiency. | 000 | 2 | NIH | 8/4/2026 | $240,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01ES034253 | Molecular mechanisms of iAs-mediated carcinogenesis through the lens of histone H2B variants | 000 | 5 | NIH | 2/11/2026 | $666,885 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35CA209859 | Establishing and Interpreting Abnormal DNA Methylation in Cancer | 000 | 11 | NIH | 7/10/2026 | $1,118,737 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | U01CA297713 | Dietary regulation of anti-tumor immunity through caloric restriction | 000 | 2 | NIH | 4/9/2026 | $767,324 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30GM154476 | Upstream Requirements for the Regulation of Mitochondrial Bioenergetics by the Mitochondrial Acyl Carrier Protein | 000 | 3 | NIH | 4/28/2026 | $49,114 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | U01CA286580 | Diet-mediated regulation of fatty acid saturation impacts cancer progression and therapy responses. | 000 | 3 | NIH | 5/1/2026 | $796,798 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152184 | Molecular mechanisms of chromatin signaling and epigenetic regulation | 000 | 3 | NIH | 5/22/2026 | $518,400 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01ES036051 | circSATB2, a novel regulator of arsenic-induced carcinogenesis | 000 | 3 | NIH | 12/16/2025 | $632,177 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AI165580 | Elucidating the Structural Mechanisms of NAIP Receptors in Bacterial Detection and Inflammasome Activation | 000 | 5 | NIH | 12/29/2025 | $480,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R25HG011020 | Epigenomics Workshop for Graduate Students | 000 | 5 | NIH | 12/15/2025 | $51,777 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG084743 | Accelerated DNA Methylation Alterations in Hutchinson-Gilford Progeria Syndrome | 000 | 4 | NIH | 6/11/2026 | $783,592 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152081 | Mechanisms and Applications of RNA-mediated Enzymes in Translation and Immunity | 001 | 4 | NIH | 3/10/2026 | $62,573 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152081 | Mechanisms and Applications of RNA-mediated Enzymes in Translation and Immunity | 000 | 4 | NIH | 1/30/2026 | $563,163 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R13HD122433 | Midwest Zebrafish Meeting 2026 | 000 | 1 | NIH | 6/9/2026 | $20,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01DK139630 | Understanding putative beta-cell subtypes | 001 | 3 | NIH | 8/13/2026 | $1,351,292 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG083568 | Endogenous retrovirus in joint aging and osteoarthritis development | 000 | 4 | NIH | 4/9/2026 | $585,279 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG077573 | Network and cellular vulnerability to pathological protein progression | 000 | 5 | NIH | 5/7/2026 | $440,318 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM147261 | Epigenetic Mechanisms of Retrotransposon Silencing | 000 | 5 | NIH | 7/9/2026 | $475,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM151245 | Regulation of mitochondrial fatty acid synthesis in the control of mitochondrial metabolism. | 000 | 4 | NIH | 5/14/2026 | $475,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA305570 | Targeting mechanisms of chromatin plasticity to improve the efficacy of epigenetic solid tumor therapy | 002 | 2 | NIH | 8/5/2026 | $52,114 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA305570 | Targeting mechanisms of chromatin plasticity to improve the efficacy of epigenetic solid tumor therapy | 001 | 1 | NIH | 5/19/2026 | $3,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | T32CA251066 | Cancer Epigenetics Training (CET) Program | 002 | 6 | NIH | 7/14/2026 | $500,218 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM131754 | Structural mechanism of DNA replication | 000 | 8 | NIH | 5/5/2026 | $720,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | K22CA272912 | Oncoprotein-regulated lineage plasticity in acute leukemia | 000 | 3 | NIH | 5/5/2026 | $192,240 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01MH139201 | The immunobiological mechanisms of depression in perimenopause | 000 | 2 | NIH | 1/16/2026 | $765,613 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AR084693 | Sexually dimorphic regulation of bone mass by the X-linked histone modifier KDM5C | 000 | 3 | NIH | 6/19/2026 | $620,093 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | DP2DK139569 | IDENTIFYING MICROBIAL MECHANISMS THAT REGULATE ANIMAL INSULIN SIGNALING | 000 | 2 | NIH | 8/12/2026 | $1,140,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM145378 | Mechanisms of mutant mitochondrial genome modulation | 002 | 6 | NIH | 1/21/2026 | $432,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM145378 | Mechanisms of mutant mitochondrial genome modulation | 004 | 6 | NIH | 3/10/2026 | $48,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA276031 | Mechanisms of cancer mutations | 001 | 4 | NIH | 4/16/2026 | $48,255 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA276031 | Mechanisms of cancer mutations | 000 | 4 | NIH | 12/10/2025 | $434,294 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA283463 | Mechanisms of DNA methylation signaling and dysregulation in colon cancer | 001 | 3 | NIH | 7/7/2026 | $1,896,957 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS146544 | Neurodegenerative Mechanisms of ATP13A2-linked Parkinson's Disease and Related Disorders | 000 | 1 | NIH | 3/10/2026 | $582,465 |
|
